NAD(P)H Dehydrogenase (NQO)
Target-specific Assays

NAD(P)H Dehydrogenase Assays (NQO)

NQO (NAD(P)H dehydrogenase quinone) proteins are responsible for preventing the one-electron reduction of quinones that results in the creation of radical species. Having been linked to Alzheimer’s disease and susceptibility to various forms of cancer, NQO proteins are potential therapeutic targets for cancer and other diseases.

  • Fluorescence-based assay for high quality activity data
  • NQO1 and NQO2 recombinant proteins are available for purchase